Charles River Laboratories Interna
$290.19Change from previous close: +1.17%Absolute change: +$3.36
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $13.76B
- Enterprise value
- $16.58B
- Forward P/E
- 22.6
- PEG
- 0.12
- Price/book
- 4.84
- Price/sales
- 3.44
- EV/EBITDA
- 19.5
- EV/revenue
- 4.15
Profitability and growth
- Gross margin
- 34.6%
- Operating margin
- 15.1%
- Net margin
- -6.0%
- ROE
- -7.5%
- ROA
- 4.1%
- Revenue growth (year over year)
- -2.7%
Financial health
- Total cash
- $192.02M
- Total debt
- $3.03B
- Debt/equity
- 1.05
- Current ratio
- 1.35
- Quick ratio
- 0.80
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $305.00
- Median price target
- $322.00
- High price target
- $357.00
- Low price target
- $145.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $12.74
- EPS estimate, current year
- $11.35
Shares and trading
- Beta
- 1.41
- Average volume
- 919.57K
- Shares outstanding
- 47.74M
- Float
- 47.22M
- Institutional ownership
- 122.8%
- Insider ownership
- 0.5%
- Short interest (% of float)
- 5.4%
- Short ratio (days)
- 2.58